What is visceral hypersensitivity?

What is Visceral Hypersensitivity

Visceral hypersensitivity is enhanced pain sensitivity to experimental gut stimulation, where normal or mildly noxious stimuli in the gastrointestinal tract are perceived as painful or intensely uncomfortable, occurring in approximately two-thirds of IBS patients. 1

Core Clinical Definition

Visceral hypersensitivity manifests as two distinct pain abnormalities: 1

• Hyperalgesia: Increased sensitivity to stimuli that are normally painful 1
• Allodynia: Non-painful stimuli are perceived as painful 1

This phenomenon is highly prevalent across all functional bowel disorders and represents a key pathophysiological mechanism in pain perception for large subgroups of patients with functional gastrointestinal disorders. 2, 3

Underlying Pathophysiological Mechanisms

Visceral hypersensitivity results from a combination of factors involving heightened sensitivity of both peripheral and central nervous systems. 1

Peripheral Sensitization

During tissue injury and inflammation, peripheral nociceptor terminals are exposed to immune and inflammatory mediators including prostaglandins, leukotrienes, serotonin, histamine, cytokines, neurotrophic factors, and reactive metabolites. 1

These inflammatory mediators act on nociceptor terminals through the following mechanism: 1

• Activation of intracellular signaling pathways 1
• Upregulation of sensitivity and excitability of nociceptor terminals 1
• Development of primary hyperalgesia at the site of injury or inflammation 1

Between 6-17% of IBS patients report symptom onset following gastroenteritis, with increased mucosal T lymphocytes documented in postinfectious IBS, suggesting an altered environment around nociceptor terminals. 4

Central Sensitization

Central sensitization develops as a secondary consequence of peripheral sensitization, creating an area of hypersensitivity in surrounding uninjured tissue (secondary hyperalgesia/allodynia). 1

This occurs through: 1

• Increased excitability and receptive fields of spinal neurons 1
• Recruitment and amplification of both non-nociceptive and nociceptive inputs from adjacent healthy tissue 1

Evidence supporting central sensitization in IBS includes: 4

• Greater radiation of pain to somatic structures during colonic stimulation compared to healthy subjects 4
• Coexistence with fibromyalgia (characterized by somatic hyperalgesia) in some IBS patients 4
• Hypersensitivity extending to more proximal gut regions 4

Central Pain Processing

Beyond peripheral and central sensitization, visceral hypersensitivity involves complex processing of sensory inputs in cortical and subcortical brain structures. 4

Functional brain imaging studies demonstrate that visceral sensation is represented in: 4

• Primary (S1) and secondary somatosensory cortex (S2): Mediating sensory discriminative aspects 4
• Paralimbic and limbic structures (anterior insula, anterior cingulate, prefrontal cortices): Mediating affective and cognitive components 4
• Subcortical regions (thalamus, periaqueductal grey matter): Also involved in visceral sensation 4

Clinical Characteristics and Prevalence

Visceral hypersensitivity has been described in 20-90% of IBS patients, with most estimates centering around two-thirds of patients. 1, 2

IBS patients demonstrate decreased pain thresholds to rectal distension, meaning they may perceive symptoms more acutely than non-IBS patients. 4

Important Clinical Pitfalls

• Hypersensitivity, although frequent, is not a constant finding among patients with IBS and cannot be considered a diagnostic marker of the condition 5
• Visceral hypersensitivity may increase during psychosocial stress and during periods of symptom exacerbation 3
• The sensitive gut can be more easily provoked by normal or abnormal motor events in the gut, which may explain symptom generation 3

Relationship to Nociplastic Pain

Visceral hypersensitivity represents a form of nociplastic pain—pain that arises from altered nociception despite no clear evidence of actual or threatened tissue damage causing activation of peripheral nociceptors. 1

Visceral nociplastic conditions, including irritable bowel syndrome, interstitial cystitis/bladder pain syndrome, and chronic prostatitis/chronic pelvic pain syndrome, receive relatively little preclinical attention despite being highly prevalent diseases. 1